Wells Fargo
ROIV icon

Wells Fargo’s Roivant Sciences ROIV Stock Holding History

Wells Fargo’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.29M Sell
121,337
-142,628
-54% -$4.21M ﹤0.01% 2988
2026
Q1 		$7.31M Buy
263,965
+250,197
+1,817% +$6.43M ﹤0.01% 2274
2025
Q4 		$299K Buy
13,768
+10,085
+274% +$199K ﹤0.01% 4836
2025
Q3 		$55.7K Buy
3,683
+225
+7% +$2.79K ﹤0.01% 5522
2025
Q2 		$39K Buy
3,458
+31
+0.9% +$336 ﹤0.01% 5595
2025
Q1 		$34.6K Sell
3,427
-4,074
-54% -$44.1K ﹤0.01% 5513
2024
Q4 		$88.7K Buy
7,501
+3,426
+84% +$40.5K ﹤0.01% 5265
2024
Q3 		$47K Buy
4,075
+1,048
+35% +$11.9K ﹤0.01% 5366
2024
Q2 		$32K Sell
3,027
-13,625
-82% -$149K ﹤0.01% 5442
2024
Q1 		$176K Sell
16,652
-9,417
-36% -$102K ﹤0.01% 4551
2023
Q4 		$293K Sell
26,069
-125,465
-83% -$1.22M ﹤0.01% 4229
2023
Q3 		$1.77M Buy
151,534
+12,402
+9% +$140K ﹤0.01% 2895
2023
Q2 		$1.4M Buy
139,132
+12,807
+10% +$115K ﹤0.01% 3192
2023
Q1 		$932K Buy
126,325
+125,588
+17,040% +$1.03M ﹤0.01% 3423
2022
Q4 		$5.89K Buy
737
+37
+5% +$206 ﹤0.01% 5722
2022
Q3 		$2K Buy
700
+52
+8% +$201 ﹤0.01% 6190
2022
Q2 		$3K Buy
648
+52
+9% +$206 ﹤0.01% 6214
2022
Q1 		$3K Buy
596
+8
+1% +$53 ﹤0.01% 6592
2021
Q4 		$6K Buy
+588
New +$4.89K ﹤0.01% 6679

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wells Fargo's ROIV Position: Q2 2026 in Review

Wells Fargo reduced its Roivant Sciences (ROIV) stake by 54% in Q2 2026, selling an estimated $4.21M and leaving 121,337 shares worth $4.29M. The position accounts for ﹤0.01% of the portfolio, ranked #2988.

Wells Fargo first reported a position in ROIV in Q4 2021 and has held it in 19 quarters since. The position peaked at $7.31M in Q1 2026. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Wells Fargo held 121,337 shares of Roivant Sciences worth $4.29M as of Q2 2026.
  • Wells Fargo sold 142,628 Roivant Sciences shares in Q2 2026, an estimated $4.21M.
  • Roivant Sciences made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #2988 holding.
  • Wells Fargo first reported a position in Roivant Sciences in Q4 2021 and has held it in 19 quarters since.
  • Wells Fargo's Roivant Sciences position peaked at $7.31M in Q1 2026.
  • 498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.